Pygeum: The Definitive Guide

What is Pygeum?

Pygeum is a Prunus africana bark extract used for urinary symptoms. Older short trials suggest possible symptom improvement, but weak reporting and obsolete comparisons limit confidence. The best-known review included 18 trials and 1,562 men, with a mean treatment duration of only 64 days. It judged the evidence suggestive but limited by small samples, poor reporting, varied preparations and few comparisons with standard therapy. [1]

Typical Pygeum Protocols

These rows reproduce sources. Do not average them into one universal regimen.

Which forms and label details matter?

Record the botanical name Prunus africana, bark extract, amount per administration, extract ratio or solvent if stated, and standardization. “African plum,” raw bark powder and a named lipid-sterol extract are not automatically equivalent.

How should it be stored?

Follow the label, close the container and protect it from heat, light and moisture.

What is it commonly used for?

Pygeum is marketed for nocturia, weak stream and other lower urinary tract symptoms attributed to benign prostate enlargement. Evidence addresses symptom relief, not prevention of prostate cancer or reversal of obstruction.

What does human research show?

The 18-trial review and quantitative meta-analysis reported moderate improvements in combined symptoms, nocturia and peak flow, but most trials were small, short and poorly reported. [1][4] Chatelain randomized 235 men to 50 mg twice daily or 100 mg once daily; both schedules improved, but the blinded phase had no placebo, so equal performance does not establish efficacy. The later ten-month extension was open and uncontrolled. [2] Melo gave one tablet containing pygeum 25 mg plus nettle 300 mg twice daily to 27 men and placebo to 22 for six months; symptoms, quality of life and flow did not differ significantly. [3]

How might it act?

Bark-extract constituents have been studied for inflammatory signaling, smooth-muscle tone and prostate growth pathways. These mechanisms neither identify the active constituent nor correct the design limitations of older trials.

How does it compare with related products?

What are the risks and interactions?

Human safety reporting is limited and short. Gastrointestinal upset is the most plausible routine complaint, while long-term, pregnancy and breastfeeding data are inadequate. Urinary retention, fever, blood in urine, kidney symptoms or rapid progression require clinical assessment.

Which medicines require review?

Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.

Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [5], [6]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.

What happens when it is stopped?

No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.

Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.

What do public communities report?

Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.

Common questions about Pygeum

Does pygeum improve nighttime urination?

Older pooled trials suggest a possible reduction, but short duration and weak reporting reduce certainty.

Is 50 mg twice daily better than 100 mg once daily?

Chatelain found similar changes; without placebo, the study cannot establish either schedule’s efficacy.

Can pygeum shrink an enlarged prostate?

The evidence does not establish durable reversal of prostate enlargement or obstruction.

Can pygeum–nettle results be assigned to pygeum?

No. Combination trials cannot isolate either ingredient.

Is bark powder equivalent to extract?

No. Plant part, extraction and standardization can change the product.

What should I track?

Exact extract, schedule, nocturia, urgency, stream, retention symptoms, adverse effects and review date.

Glossary

Terms for reading the evidence.

Extract identity

Species, plant part, solvent or ratio, and any standardization used to define a preparation.

Amount per administration

Amount taken at one time, distinct from daily total.

IPSS / AUASI

Questionnaires rating lower urinary tract symptom severity; they do not diagnose the cause.

Qmax

Maximum measured urinary flow rate.

PSA

A prostate-related blood marker; it is not a stand-alone cancer test.

Monotherapy

The ingredient was tested without another active intervention.

How this guide was researched

Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources